Dorokhin Aleksei, Lipaikin Sergei, Ryltseva Galina, Shabanov Alexander, Sapozhnikova Kristina, Volova Tatiana, Kachin Sergei, Shishatskaya Ekaterina
Siberian Federal University, 79 Svobodny pr., Krasnoyarsk 660041, Russia.
L.V. Kirensky Institute of Physics, Siberian Branch of the Russian Academy of Sciences, 50/12 Akademgorodok, Krasnoyarsk 660036, Russia.
ADMET DMPK. 2025 Jun 4;13(3):2723. doi: 10.5599/admet.2723. eCollection 2025.
Polyhydroxyalkanoates (PHAs) are biodegradable polyesters of bacterial origin that are actively studied as matrices for the preparation of nanoparticulate drug delivery systems. The most significant parameters affecting PHAs nanoparticles (NPs) characteristics are polymer composition and the type of surfactant used to stabilize the emulsion during NPs preparation. However, there are only a few studies in the literature investigating the effect of these factors on the characteristics of PHA NPs.
Blank poly(3-hydroxybutyrate) (P3HB) and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (P3HBV) NPs were produced and characterized in terms of their size, morphology and zeta potential. Poly(vinyl alcohol) (PVA) with various molecular weights (31-50 and 85-124 kDa), as well as Tween 20 (TW20), Tween 80 (TW80), sodium deoxycholate (SDC) and sodium dodecyl sulphate (SDS) were used as surfactants. For NPs that formed stable aqueous suspensions and had the most desirable characteristics (P3HB/PVA and P3HBV/PVA), hemolytic activity and cytotoxicity to HeLa and C2C12 cells in vitro were determined.
NPs of both P3HB and P3HBV obtained using PVA with the of 31-50 kDa as a surfactant had regular spherical shape, uniform size distribution, average diameter of about 900 nm and zeta potential of -28.5 and -28.7 mV, respectively. PVA, TW20 and TW80, as well as SDC and SDS as surfactants, did not show satisfactory results due to suspension gelation, formation of hollow NPs with irregular shape and poor resuspension after washing and freeze-drying, respectively. P3HB/PVA and P3HBV/PVA NPs did not have hemolytic activity and did not show pronounced cytotoxicity to HeLa and C2C12 cells in the concentration range from 10 to 500 μg mL, so these samples were regarded as safe and biocompatible.
In this study, the effect of various non-ionic and anionic surfactants on the characteristics of P3HB and P3HBV NPs was investigated. PVA was found to be effective in producing NPs of both studied polymers with good biocompatibility and favorable characteristics, making them suitable for drug delivery applications. In contrast, other studied surfactants, , PVA, TW20, TW80, SDC and SDS, require further investigation. The obtained findings may promote the development of novel PHA-based nanomedicines.
聚羟基脂肪酸酯(PHA)是细菌来源的可生物降解聚酯,作为制备纳米颗粒药物递送系统的基质正受到广泛研究。影响PHA纳米颗粒(NP)特性的最重要参数是聚合物组成以及在NP制备过程中用于稳定乳液的表面活性剂类型。然而,文献中仅有少数研究探讨这些因素对PHA NPs特性的影响。
制备了空白聚(3-羟基丁酸酯)(P3HB)和聚(3-羟基丁酸酯-co-3-羟基戊酸酯)(P3HBV)纳米颗粒,并对其大小、形态和zeta电位进行了表征。使用了不同分子量(31 - 50 kDa和85 - 124 kDa)的聚乙烯醇(PVA)以及吐温20(TW20)、吐温80(TW80)、脱氧胆酸钠(SDC)和十二烷基硫酸钠(SDS)作为表面活性剂。对于形成稳定水悬浮液且具有最理想特性的NP(P3HB/PVA和P3HBV/PVA),测定了其体外对HeLa和C2C12细胞的溶血活性和细胞毒性。
以31 - 50 kDa的PVA作为表面活性剂制备的P3HB和P3HBV纳米颗粒均呈规则球形,尺寸分布均匀,平均直径约为900 nm,zeta电位分别为 - 28.5 mV和 - 28.7 mV。PVA、TW20和TW80以及SDC和SDS作为表面活性剂时,分别由于悬浮液凝胶化、形成形状不规则的空心NP以及洗涤和冷冻干燥后再悬浮性差而未显示出令人满意的结果。P3HB/PVA和P3HBV/PVA纳米颗粒在10至500 μg/mL的浓度范围内没有溶血活性,对HeLa和C2C12细胞也没有明显的细胞毒性,因此这些样品被认为是安全且具有生物相容性的。
在本研究中,研究了各种非离子和阴离子表面活性剂对P3HB和P3HBV纳米颗粒特性的影响。发现PVA可有效制备具有良好生物相容性和理想特性的两种研究聚合物的纳米颗粒,使其适用于药物递送应用。相比之下,其他研究的表面活性剂,即PVA、TW20、TW80、SDC和SDS,需要进一步研究。所获得的研究结果可能会促进新型PHA基纳米药物的开发。